U.S. Avidity Biosciences, Broadcom, Cara Therapeutics
June 13 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avidity Biosciences, Broadcom and Cara Therapeutics, on Thursday.
HIGHLIGHTS
* Avidity Biosciences Inc RNA.O: Leerink Partners raises target price to $56 from $38 |
* Broadcom Inc AVGO.O: TD Cowen raises target price to $1,750 from $1,500 |
* Cara Therapeutics Inc CARA.O: Canaccord Genuity cuts to hold from buy |
* Labcorp LH.N: Baird raises target price to $258 from $256 |
* Meritage Homes Corp MTH.N: Evercore ISI raises target price to $219 from $217 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* 3M Co MMM.N: Wolfe Research raises to outperform from peer perform |
* Albemarle Corp ALB.N: UBS cuts target price to $124 from $132 |
* Allegro Microsystems Inc ALGM.O: TD Cowen raises target price to $35 from $32 |
* Amphenol APH.N: Evercore ISI adjusts PT to $75 from $150 to reflect 2-for-1 stock split |
* Amphenol APH.N: Stifel adjusts PT to $66 from $112 to reflect 2-for-1 stock split |
* Ares Management Corp ARES.N: Deutsche Bank resumes coverage with hold rating; PT $132 |
* Atlassian Corp TEAM.O: Citigroup adds stock to its north american focus list |
* Avidity Biosciences Inc RNA.O: BofA Global Research raises PT to $45 from $40 |
* Avidity Biosciences Inc RNA.O: Evercore ISI raises target price to $45 from $40 |
* Avidity Biosciences Inc RNA.O: Leerink Partners raises target price to $56 from $38 |
* Avidity Biosciences Inc RNA.O: Needham raises target price to $46 from $35 |
* Avidity Biosciences Inc RNA.O: Raymond James raises target price to $90 from $66 |
* Barnes Group Inc B.N: D.A. Davidson raises target price to $48 from $45 |
* Boeing BA.N: BofA Global Research raises price objective to $200 from $180 |
* Broadcom Inc AVGO.O: Barclays raises target price to $2000 from $1500 |
* Broadcom Inc AVGO.O: Benchmark raises target price to $2,100 from $1,750 |
* Broadcom Inc AVGO.O: Bernstein raises target price to $1,950 from $1,600 |
* Broadcom Inc AVGO.O: BofA Global Research raises price objective to $2000 from $1680 |
* Broadcom Inc AVGO.O: Evercore ISI raises target price to $2010 from $1620 |
* Broadcom Inc AVGO.O: Jefferies raises target price to $2050 from $1550 |
* Broadcom Inc AVGO.O: JP Morgan raises target price to $2000 from $1700 |
* Broadcom Inc AVGO.O: Mizuho raises target price to $1,900 from $1,625 |
* Broadcom Inc AVGO.O: Morgan Stanley raises target price to $1,765 from $1,658 |
* Broadcom Inc AVGO.O: Oppenheimer raises target price to $2000 from $1500 |
* Broadcom Inc AVGO.O: Rosenblatt Securities raises target price to $1,650 from $1,500 |
* Broadcom Inc AVGO.O: Susquehanna raises target price to $2,000 from $1,650 |
* Broadcom Inc AVGO.O: TD Cowen raises target price to $1,750 from $1,500 |
* Broadcom Inc AVGO.O: Truist Securities raises target price to $2,045 from $1,566 |
* Broadcom Inc AVGO.O: UBS raises target price to $1,735 from $1,610 |
* Broadcom Inc AVGO.O: Wells Fargo raises target price to $1,700 from $1,430 |
* Cara Therapeutics Inc CARA.O: Canaccord Genuity cuts to hold from buy |
* Cara Therapeutics Inc CARA.O: Needham cuts to hold from buy |
* Cara Therapeutics Inc CARA.O: Stifel cuts to hold from buy; cuts PT to $1 from $6 |
* Caretrust REIT Inc CTRE.N: BMO raises target price to $29 from $27 |
* Caseys General Stores Inc CASY.O: Benchmark raises target price to $410 |
* Caseys General Stores Inc CASY.O: BMO raises target price to $400 from $305 |
* Caseys General Stores Inc CASY.O: Deutsche Bank raises target price to $420 from $375 |
* Caseys General Stores Inc CASY.O: Jefferies raises target price to $445 from $342 |
* Caseys General Stores Inc CASY.O: Wells Fargo raises target price to $415 from $340 |
* Cava Group Inc CAVA.N: TD Cowen raises target price to $95 from $90 |
* Celsius Holdings Inc CELH.O: Jefferies cuts target price to $98 from $104 |
* Celsius Holdings Inc CELH.O: TD Cowen cuts target price to $85 from $95 |
* Charles River Laboratories International Inc CRL.N: Baird raises PT to $271 from $270 |
* Chipotle Mexican Grill Inc CMG.N: Goldman Sachs initiates coverage with buy rating |
* Chipotle Mexican Grill Inc CMG.N: Goldman Sachs initiates coverage with PT $3,730 |
* Chipotle Mexican Grill Inc CMG.N: TD Cowen raises target price to $3,600 from $3,500 |
* Civitas Resources Inc CIVI.N: TD Cowen initiates coverage with buy rating; PT $90 |
* Clean Harbors Inc CLH.N: Oppenheimer raises target price to $245 from $218 |
* Coca-Cola Co KO.N: Citigroup adds stock to its north american focus list |
* Corning Inc GLW.N: Jefferies raises target price to $33.5 from $30 |
* Corning Inc GLW.N: Morgan Stanley cuts to equal-weight from overweight |
* Corning Inc GLW.N: Morgan Stanley raises target price to $38 from $35 |
* Darden Restaurants Inc DRI.N: BofA Global Research cuts PT to $180 from $194 |
* Darden Restaurants Inc DRI.N: Evercore ISI cuts target price to $165 from $170 |
* Darden Restaurants Inc DRI.N: TD Cowen cuts target price to $170 from $190 |
* Darling Ingredients Inc DAR.N: TD Cowen cuts target price to $45 from $51 |
* Dave & Buster'S Entertainment Inc PLAY.O: BMO cuts target price to $65 from $75 |
* Dave & Buster'S Entertainment Inc PLAY.O: Jefferies cuts target price to $75 from $80 |
* Dave & Buster'S Entertainment Inc PLAY.O: Truist Securities cuts PT to $64 from $67 |
* Domino's Pizza Inc DPZ.N: Goldman Sachs initiates coverage with buy rating; target price $612 |
* Domino's Pizza Inc DPZ.N: TD Cowen raises target price to $610 from $580 |
* Dutch Bros Inc BROS.N: TD Cowen raises target price to $50 from $46 |
* Enovis Corp ENOV.N: JP Morgan initiates coverage with neutral rating; price target $53 |
* Evergy Inc EVRG.O: Citigroup adds stock to its north american focus list |
* First Horizon Corp FHN.N: Citigroup removes stock from its north american focus list |
* First Watch Restaurant Group Inc FWRG.O: TD Cowen cuts target price to $21 from $25 |
* FMC Corp FMC.N: UBS cuts target price to $81 from $86 |
* Fox Factory Holding Corp FOXF.O: Truist Securities raises PT to $55 from $50 |
* Ftai Aviation Ltd FTAI.O: Morgan Stanley raises target price to $105 from $85 |
* General Mills Inc GIS.N: Jefferies cuts target price to $69 from $71 |
* Goodyear Tire & Rubber Co GT.O: Morgan Stanley initiates coverage with equal weight rating |
* Goodyear Tire & Rubber Co GT.O: Morgan Stanley initiates coverage with target price $14 |
* Hertz Global HTZ.O: BofA Global Research cuts price objective to $2.5 from $3 |
* Hims & Hers Health Inc HIMS.N: BofA Global Research raises PT to $26 from $22 |
* Huntington Bancshares Inc HBAN.O: UBS cuts target price to $15 from $16 |
* Iqvia Holdings Inc IQV.N: Baird cuts target price to $241 from $245 |
* Jack In the Box Inc JACK.O: Goldman Sachs initiates coverage with sell rating; PT $55 |
* Kimberly-Clark Corp KMB.N: BofA Global Research raises to buy from underperform |
* Kimberly-Clark Corp KMB.N: BofA Global Research ups price objective to $160 from $115 |
* Kontoor Brands Inc KTB.N: Wells Fargo raises target price to $80 from $76 |
* Kura Oncology Inc KURA.O: BofA Global Research raises price objective to $35 from $33 |
* Labcorp LH.N: Baird raises target price to $258 from $256 |
* Lear Corp LEA.N: UBS cuts target price to $136 from $142 |
* Lexeo Therapeutics Inc LXEO.O: Baird initiates coverage with outperform rating; PT $28 |
* Matador Resources Co MTDR.N: Raymond James raises target price to $79 from $77 |
* Matador Resources Co MTDR.N: Truist Securities raises target price to $91 from $87 |
* McDonald's MCD.N: Goldman Sachs initiates coverage with neutral rating; target price $288 |
* Medpace Holdings Inc MEDP.O: Baird raises target price to $456 from $454 |
* Meritage Homes Corp MTH.N: Evercore ISI raises target price to $219 from $217 |
* Monolithic Power Systems Inc MPWR.O: Oppenheimer raises target price to $900 from $750 |
* Monster Beverage Corp MNST.O: Jefferies cuts target price to $61 from $68 |
* National Health Investors Inc NHI.N: BMO raises target price to $74 from $67 |
* National Vision Holdings Inc EYE.O: BofA Global Research cuts PT to $16 from $17 |
* Nextera Energy Inc NEE.N: Barclays cuts target price to $73 from $74 |
* Nike Inc NKE.N: Deutsche Bank resumes coverage with buy rating; price target $115 |
* Omega Healthcare Investors Inc OHI.N: BMO raises target price to $37 from $35 |
* Oxford Industries Inc OXM.N: Citigroup cuts target price to $92 from $94 |
* Oxford Industries Inc OXM.N: UBS cuts target price to $101 from $104 |
* PAR Technology Corp PAR.N: Stephens raises target price to $60 from $46 |
* PAR Technology Corp PAR.N: Stephens raises to overweight from equal-weight |
* PG&E Corp PCG.N: RBC raises target price to $22 from $21 |
* Regency Centers Corp REG.O: Deutsche Bank cuts target price to $70 from $74 |
* Roblox Corp RBLX.N: Wells Fargo raises target price to $41 from $37 |
* Royal Caribbean Group RCL.N: Citigroup adds stock to its north american focus list |
* Rubrik Inc RBRK.N: Citigroup raises target price to $47 from $46 |
* Saia Inc SAIA.O: BMO raises target price to $500 from $490 |
* Scholar Rock Holding Corp SRRK.O: BMO raises target price to $31 from $29 |
* Shake Shack Inc SHAK.N: Goldman Sachs initiates coverage with buy rating; target price $110 |
* Simulations Plus Inc SLP.O: Craig-Hallum raises target price to $56 from $51 |
* Simulations Plus Inc SLP.O: Oppenheimer raises target price to $65 from $55 |
* Skechers USA Inc SKX.N: Deutsche Bank resumes coverage with buy rating; PT $82 |
* Skechers USA Inc SKX.N: Monness Crespi Hardt raises target price to $85 from $72 |
* SL Green Realty Corp SLG.N: Citigroup raises target price to $37 from $31 |
* Spruce Biosciences SPRB.O: Oppenheimer cuts target price to $3 from $4 |
* Starbucks SBUX.O: Goldman Sachs initiates coverage with buy rating; target price $100 |
* Sweetgreen Inc SG.N: Goldman Sachs initiates coverage with buy rating; target price $39 |
* Sweetgreen Inc SG.N: TD Cowen raises target price to $31 from $26 |
* Syndax Pharmaceuticals Inc SNDX.O: BofA Global Research raises PT to $31 from $29 |
* Torrid Holdings Inc CURV.N: Jefferies raises target price to $7 from $4.8 |
* Torrid Holdings Inc CURV.N: Telsey Advisory Group raises target price to $8 from $6 |
* Twist Bioscience Corp TWST.O: TD Cowen raises target price to $65 from $55 |
* Ventas Inc VTR.N: BMO raises target price to $57 from $53 |
* Viavi Solutions Inc VIAV.O: Morgan Stanley cuts target price to $9.00 from $10.00 |
* Vicarious Surgical Inc RBOT.N: Morgan Stanley raises target price to $18.00 from $0.60 |
* Walmart WMT.N: Citigroup removes stock from its north american focus list |
* Welltower Inc WELL.N: BMO raises target price to $115 from $110 |
* Wendy's Co WEN.O: Goldman Sachs initiates coverage with sell rating; target price $16 |
* Williams Companies Inc WMB.N: RBC raises target price to $44 from $40 |
* Wingstop Inc WING.O: Goldman Sachs initiates coverage with neutral rating; PT $407 |
* Wingstop Inc WING.O: TD Cowen raises target price to $450 from $430 |
* Yum Brands YUM.N: Goldman Sachs initiates coverage with neutral rating; PT $150 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
